Bacterial abortive infection (Abi) systems are ‘altruistic’ cell death systems that are activated by phage infection and limit viral replication, thereby providing protection to the bacterial population. Here, we have used a novel approach of screening Abi systems as a tool to identify and characterize toxin–antitoxin (TA)-acting Abi systems. We show that AbiE systems are encoded by bicistronic operons and function via a non-interacting (Type IV) bacteriostatic TA mechanism. The abiE operon was negatively autoregulated by the antitoxin, AbiEi, a member of a widespread family of putative transcriptional regulators. AbiEi has an N-terminal winged-helix-turn-helix domain that is required for repression of abiE transcription, and an uncharacterized bi-functional C-terminal domain, which is necessary for transcriptional repression and sufficient for toxin neutralization. The cognate toxin, AbiEii, is a predicted nucleotidyltransferase (NTase) and member of the DNA polymerase β family. AbiEii specifically bound GTP, and mutations in conserved NTase motifs (I-III) and a newly identified motif (IV), abolished GTP binding and subsequent toxicity. The AbiE systems can provide phage resistance and enable stabilization of mobile genetic elements, such as plasmids. Our study reveals molecular insights into the regulation and function of the widespread bi-functional AbiE Abi-TA systems and the biochemical properties of both toxin and antitoxin proteins.
Osmoregulation is of central importance for living cells. In Gram-negative bacteria, strategies for osmoregulation and turgor maintenance in hypotonic environments include the synthesis, accumulation, and modification of periplasmic oligosaccharides. These osmoregulated periplasmic glucans (OPGs, formerly known as membrane-derived oligosaccharides or MDOs) promote water uptake and retention, keeping the cells in an optimal state of hydration. While our understanding of OPG-dependent osmoregulation in a number of model organisms like Escherichia coli is quite detailed, less is known about these processes in bacteria that live in environments characterized by strongly fluctuating osmolarity, such as soil. Here we describe that the soil bacterium Myxococcus xanthus lacks a canonical low-molecular-weight OPG, but instead possesses a novel high-molecular-weight, fiber-forming polysaccharide. Chemical analysis reveals that this polysaccharide is several thousand kilodaltons in size, composed of a highly branched decasaccharide repeat unit containing mannose, glucose, N-acetylglucosamine, and rhamnose. Physiological experiments indicate that the polysaccharide is osmoregulated thereby functionally replacing the canonical OPG. Moreover, experiments indicate that this high-molecular-weight periplasmic polysaccharide forms a fibrillar meshwork that stabilizes the cell envelope during glycerol spore formation, a process during which the entire peptidoglycan of the cell is degraded and the rod-shaped vegetative cells convert into spherical spores.SignificanceOsmoprotection is a necessity for every living cell, particularly in an environment with fluctuating osmolarity. In Gram-negative bacteria, low-molecular-weight osmoregulated periplasmic glucans (OPGs) are an important component of the osmotic stress response in hypotonic environments. Here, we describe that the soil bacterium Myxococcus xanthus does not possess such an OPG but instead accumulates a novel high-molecular-weight fiber-forming polysaccharide in the periplasm in response to hypotonic conditions. This polymer is important for osmoprotection of the cells and plays a key role in the stabilization of the cell envelope during the conversion of rod-shaped vegetative cells into spherical spores. These results indicate that bacteria may use non-OPG carbohydrates for osmoprotection and cell wall stabilization during processes like cellular differentiation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.